Rhumbline Advisers Lowers Stake in National HealthCare Co. (NHC)
Rhumbline Advisers cut its holdings in National HealthCare Co. (NYSEAMERICAN:NHC) by 40.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 15,329 shares of the company’s stock after selling 10,287 shares during the quarter. Rhumbline Advisers owned approximately 0.10% of National HealthCare worth $959,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Acrospire Investment Management LLC increased its position in National HealthCare by 235.0% in the second quarter. Acrospire Investment Management LLC now owns 1,568 shares of the company’s stock worth $110,000 after purchasing an additional 1,100 shares during the period. BNP Paribas Arbitrage SA increased its position in National HealthCare by 286.1% in the second quarter. BNP Paribas Arbitrage SA now owns 2,081 shares of the company’s stock worth $146,000 after purchasing an additional 1,542 shares during the period. Legal & General Group Plc increased its position in National HealthCare by 3.0% in the second quarter. Legal & General Group Plc now owns 2,769 shares of the company’s stock worth $195,000 after purchasing an additional 81 shares during the period. Principal Financial Group Inc. acquired a new stake in National HealthCare in the second quarter worth about $206,000. Finally, Virtu KCG Holdings LLC increased its position in National HealthCare by 9.0% in the second quarter. Virtu KCG Holdings LLC now owns 3,267 shares of the company’s stock worth $229,000 after purchasing an additional 269 shares during the period.
Shares of National HealthCare Co. (NHC) traded down $0.62 during mid-day trading on Thursday, reaching $62.45. The company had a trading volume of 48,700 shares, compared to its average volume of 28,724. National HealthCare Co. has a 1 year low of $57.73 and a 1 year high of $78.99.
National HealthCare (NYSEAMERICAN:NHC) last announced its quarterly earnings data on Thursday, November 9th. The company reported $0.75 EPS for the quarter. National HealthCare had a return on equity of 6.60% and a net margin of 4.62%. The firm had revenue of $241.99 million during the quarter.
The business also recently announced a quarterly dividend, which will be paid on Thursday, March 1st. Shareholders of record on Friday, December 29th will be issued a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date is Thursday, December 28th. National HealthCare’s dividend payout ratio (DPR) is currently 43.13%.
In other National HealthCare news, SVP Jeffrey Russell Smith sold 1,848 shares of the firm’s stock in a transaction dated Thursday, September 28th. The stock was sold at an average price of $62.78, for a total transaction of $116,017.44. Following the transaction, the senior vice president now owns 3,111 shares in the company, valued at $195,308.58. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director James Paul Abernathy sold 800 shares of the firm’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $64.00, for a total value of $51,200.00. Following the transaction, the director now owns 23,478 shares in the company, valued at approximately $1,502,592. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,147 shares of company stock worth $267,740.
A number of analysts recently commented on NHC shares. BidaskClub upgraded National HealthCare from a “strong sell” rating to a “sell” rating in a research report on Tuesday, September 12th. ValuEngine lowered National HealthCare from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd.
TRADEMARK VIOLATION NOTICE: This news story was published by Daily Political and is the property of of Daily Political. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/12/14/rhumbline-advisers-lowers-stake-in-national-healthcare-co-nhc.html.
About National HealthCare
National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company is engaged in the post-acute healthcare industry segment. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer’s care, senior living services, and home healthcare services.
Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Co. (NYSEAMERICAN:NHC).
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.